| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2017↕ | FY 2016↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.7B | $7.8B | $8.7B | $8.2B | $6.8B | $1.8B | $5.3B | $5.1B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | $3.6B | $3.3B | $3.7B | $3.6B | $2.6B | $0.7B | $1.9B | $1.9B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $2.2B | $2.1B | $2.2B | $2.2B | $1.7B | $1.7B | $1.5B | $1.4B |
| Operating Income | $1.4B | $1.2B | $1.5B | $1.5B | $0.9B | $0.2B | $0.5B | $0.5B |
| Net Income | $1.1B | $0.9B | $1.1B | $1.1B | $0.7B | $0.2B | $0.3B | $0.3B |
| EPS (Basic) | $8.91 | $14.71 | $16.58 | $15.17 | $8.81 | $2.15 | $3.03 | $3.45 |
| EPS (Diluted) | $8.79 | $14.55 | $16.32 | $14.75 | $8.61 | $2.10 | $3.02 | $3.41 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2017↕ | FY 2016↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.3B | $5.3B | $4.7B | $4.6B | $4.7B | $4.1B | $2.8B | $2.5B |
| Current Assets | $2.8B | $2.7B | $2.0B | $2.3B | $2.5B | $1.8B | $1.6B | $1.4B |
| Cash & Equivalents | $1.2B | $1.3B | $0.4B | $0.9B | $1.2B | $0.4B | $0.4B | $0.2B |
| Total Liabilities | $3.2B | $3.1B | $3.0B | $3.0B | $3.0B | $2.8B | $1.6B | $1.2B |
| Current Liabilities | $1.9B | $1.9B | $1.6B | $1.8B | $1.8B | $1.6B | $1.0B | $1.0B |
| Stockholders' Equity | $2.1B | $2.1B | $1.7B | $1.7B | $1.7B | $1.2B | $1.2B | $1.2B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2017↕ | FY 2016↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.4B | $1.7B | $1.1B | $1.4B | $1.3B | $0.6B | — | — |
| Investing Cash Flow | $-0.2B | $-0.2B | $-0.4B | $-0.2B | $-0.2B | $-0.2B | — | — |
| Capital Expenditures | $0.2B | $0.2B | $0.4B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B |
| Financing Cash Flow | $-1.2B | $-0.6B | $-1.2B | $-1.5B | $-0.3B | $-0.3B | — | — |